Bacillus engineering bacteria and application thereof in inhibition of agricultural pathogenic bacteria
Through ARTP mutagenesis and microbial droplet culture system, the iterative evolution of Bacillus IMD4001 was assisted, and a high-yield Bacillus engineering strain IMD4036 was constructed, which solved the problems of low bioantibiotic yield and high production cost, and achieved the goal of a variety of agricultural pests and diseases. Effective prevention and treatment.
Patent Information
- Application Number
- CN202411024648.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-12
AI Technical Summary
In the prior art, bioantibiotics have low yield and high production costs, and low efficiency of mutagenesis methods, resulting in limited application in agricultural biocontrol.
By combining Atmospheric Room Temperature Plasma (ARTP) mutagenesis and microbial droplet culture system, a high-yield Bacillus engineering strain IMD4036 was constructed to improve macrolide, surfactant and abundance of the microbial microdroplet culture system. and broaden its antibacterial spectrum.
The yield of macrolides and surfactants of Bacillus engineered bacteria IMD4036 has been significantly improved, the antibacterial spectrum of agricultural pathogenic bacteria has been expanded, the production cost has been reduced, and the effective prevention and control of a variety of agricultural pests and diseases has been achieved.
Smart Images

Figure CN118931772A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of bioengineering, and in particular to an engineering bacillus and its application in inhibiting agricultural pathogenic bacteria. Background Art
[0002] Although chemical pesticides play an important role in agricultural biological control, their residues pose a serious threat to the environment and human health. Therefore, actively seeking biological control methods is currently a research hotspot. Active compounds such as macrolides, surfactants, and fengycin derived from microorganisms have been proven to be active against agricultural pathogens and are a class of safe, non-toxic, and easily degradable natural antibiotics. However, low yields and high production costs have seriously hindered their widespread application in agricultural pest control. Therefore, breeding high-performance engineered strains is a direct and key strategy to solve the current dilemma.
[0003] In previous studies, the inventors' existing studies found that the salt tolerance of Bacillus IMD4001 was positively correlated with its macrolide yield, that is, improving salt tolerance can improve the metabolic efficiency of macrolides of the strain. The main strategies used to improve microbial stress tolerance include metabolic engineering, mutagenesis, and adaptive laboratory evolution (ALE). Compared with metabolic engineering, mutagenesis and ALE are simpler and more effective methods to improve strain stress resistance. Since stress tolerance is a complex phenotype involving multiple genes, it is a challenge to develop a rational design to improve it. Although ultraviolet or chemical mutagenesis is the most common and economical microbial breeding method, its mutation efficiency is low. In order to solve this problem, a variety of new and efficient mutagenesis technologies have been developed and successfully applied to specific breeding of microorganisms. Atmospheric Room Temperature Plasma (ARTP)-mediated mutagenesis has become a whole-cell mutagenesis tool, relying on plasma jets to cause DNA mutations with higher efficiency than ultraviolet or chemical mutagenesis. To date, ARTP has been applied to enhance many aspects of microbial stress tolerance, such as acid resistance, salt resistance, and heat resistance. However, in the process of mutagenesis of ARTP, there are still deficiencies in terms of uncertainty in the direction of mutagenesis and genetic instability. To address this issue, researchers usually combine different mutagenesis methods to improve the stress tolerance of different strains, thereby broadening its application potential in industrial microbial breeding.
[0004] ALE is another powerful microbial breeding strategy, which mainly involves the selection of stress-tolerant strains by continuously subculturing the strains under appropriate selection pressure to enrich the target phenotype of the strains. However, traditional ALE methods have inherent limitations: they are labor-intensive, have poor parallelism, and are time-consuming to execute. For example, researchers using ALE technology need to spend up to 420 days to continuously culture microorganisms to improve cell phenotypes. Automated microbial cell microculture systems assist microbial evolution and have attracted attention due to their low labor costs, high-throughput data analysis, and superior characteristics in parallelism. Summary of the invention
[0005] The purpose of the present invention is to provide an engineered bacillus bacterium to solve the problems of low yield and high production cost of biological antibiotics in the prior art and high limitations of existing mutagenesis methods.
[0006] Another object of the present invention is to provide a method for constructing the Bacillus engineered bacteria.
[0007] Another object of the present invention is to provide an application of the Bacillus engineered bacteria.
[0008] The technical solution adopted to achieve the purpose of the present invention is:
[0009] A Bacillus engineered bacterium IMD4036, wherein the Bacillus engineered bacterium IMD4036 is Bacillus velezensis, and the Bacillus engineered bacterium IMD4036 is deposited in Guangdong Provincial Microbiological Culture Collection Management Center, with a deposit number of GDMCC No.64728 and a deposit date of June 7, 2024.
[0010] In the above technical solution, the Bacillus engineered bacteria IMD4036 produces macrolide, surfactant and fengycin.
[0011] In the above technical solution, the titer of macrolide produced by the Bacillus engineered bacteria IMD4036 is not less than 350 μg / mL, the titer of surfactant produced by the Bacillus engineered bacteria IMD4036 is not less than 50 μg / mL, and the titer of fengyrin produced by the Bacillus engineered bacteria IMD4036 is not less than 180 μg / mL.
[0012] In the above technical solution, the engineered Bacillus sp. IMD4036 is obtained by ARTP mutagenesis and microbial droplet culture system-assisted iterative evolution of Bacillus sp. IMD4001.
[0013] Another aspect of the present invention provides a method for constructing the Bacillus engineered bacteria IMD4036, comprising the following steps:
[0014] Step 1: Pick a single clone of Bacillus IMD4001 and inoculate it into medium A for overnight culture to obtain a seed culture. Then transfer the seed culture to medium B. The initial OD 600 The value is 0.1. After culturing to the mid-logarithmic phase, the cells are collected by centrifugation and washed with sterile water. The cells are diluted and the suspension is dropped onto the ARTP mutagenesis sterile iron sheet. After being treated by the ARTP mutation breeding system, the cells are washed off the iron sheet using the seed culture medium and revived. The revived cells are transferred to the culture medium B to enrich the salt-tolerant mutant strains in the ARTP mutagenesis library.
[0015] Step 2, performing a first round of MMC system-assisted Bacillus evolution to improve the salt tolerance of the salt-tolerant mutant strain obtained in step 1;
[0016] Step 3, when a second round of MMC system-assisted Bacillus evolution is performed, the salt tolerance of the salt-tolerant mutant strain is again improved until the salt concentration is too high to inhibit cell growth;
[0017] Step 4: Select the droplet with the fastest cell growth in step 3 and culture it in medium B containing 10% sea salt until the OD 600 The value reached 1.0, and an excellent salt-tolerant strain numbered IMD4036 was obtained through culture, which was the engineered Bacillus sp. IMD4036.
[0018] In the above technical solution, the culture medium A includes 2 g / L yeast extract, 2 g / L malt extract, 2 g / L glucose and 3% (w / v) sea salt.
[0019] In the above technical solution, the culture medium B includes 50 g / L glucose, 10 g / L yeast extract, 6 g / L malt extract and 7% to 10% (w / v) sea salt.
[0020] Another aspect of the present invention provides a use of the Bacillus engineered bacteria IMD4036 as a bactericide.
[0021] Another aspect of the present invention provides a microbial agent, comprising the Bacillus engineered bacteria IMD4036.
[0022] Another aspect of the present invention provides a use of the microbial agent in the prevention and treatment of sugarcane tip rot, banana wilt, grape gray mold, tomato bacterial wilt, monk fruit bacterial wilt, bitter melon bacterial wilt or pitaya canker.
[0023] Compared with the prior art, the present invention has the following beneficial effects:
[0024] 1. The present invention combines ARTP mutagenesis and microbial microdroplet culture (MMC) system to assist the evolution of Bacillus IMD4001, and finally obtains a Bacillus engineered bacterium IMD4036 with improved macrolide and surfactant metabolism performance, further expanding the antibacterial spectrum against agricultural pathogens. The present invention can provide potential strain resources for broad-spectrum resistance to agricultural pathogens, and the technical means used provide references for the breeding of metabolic strains of other toxic compounds, antibiotics, etc.
[0025] 2. Under the optimal fermentation conditions, the titers of macrolide and fengyuan in the fermentation broth of the Bacillus engineered bacteria IMD4036 of the present invention are 409.4±9.7μg / mL and 59.2±7.2μg / mL, and the yields are increased by 246.6% and -72.7% respectively compared with the control group IMD4001. According to the results of the transcriptome study, the surfactant synthesis pathway of the strain was successfully activated by downregulating the transcription level of the fengyuan gene cluster, and the surfactant titer of the IMD4036 fermentation broth was 252.4±57.5μg / mL.
[0026] 3. The Bacillus engineered bacteria IMD4036 of the present invention has inhibitory activity against banana wilt, grape gray mold, sugarcane tip rot, pitaya canker, tomato bacterial wilt, monk fruit bacterial wilt and bitter melon bacterial wilt, and exhibits a wider antibacterial spectrum than the original strain IMD4001. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 The figure shows the metabolic performance evaluation of the Bacillus engineered strain IMD4036 of the present invention, wherein: Figure 1 Among them, A is macrolide, B is fengyrin, and C is a surfactant.
[0028] Figure 2 Shown is the evaluation of the activity of the original strain IMD4001 against agricultural pathogens.
[0029] Figure 3 The figure shows the activity evaluation of the Bacillus engineered strain IMD4036 of the present invention against agricultural pathogens.
[0030] The Bacillus engineered bacteria IMD4036 of the present invention is Bacillus velezensis, and the Bacillus engineered bacteria IMD4036 is deposited in the Guangdong Provincial Microbiological Culture Collection Center (GDMCC), the address of the depository unit is: 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou, the deposit number is: GDMCC No. 64728, and the deposit date is: June 7, 2024. DETAILED DESCRIPTION
[0031] The present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0032] In this specific embodiment, the original strain IMD4001 is constructed by Bacillus A72 (for details of the construction method, see Gan Y, Bai M, Lin X, et al. Improvement of macrolactins production by the genetic adaptation of Bacillus siamensisA72 to saline stress via adaptive laboratory evolution[J]. Microbial Cell Factories, 2022, 21(1): 1-15. DOI: 10.1186 / s12934-022-01871-9.), and the Bacillus A72 is constructed by Bacillus IMDGX0108 (for details of the construction method, see Yi X, Gan Y, Jiang L, et al. Rapid improvement in the macrolactins production of Bacillus sp. combining atmospheric room temperature plasma with the specific growth rate index[J]. Journal of Bioscience and Bioengineering, 2020, 130(1): 48-53. DOI: 10.1016 / j.jbiosc.2020.02.014.), the Bacillus IMDGX0108 was collected from Fangchenggang City, Guangxi Zhuang Autonomous Region in October 2016.
[0033] Example 1
[0034] A Bacillus engineered bacterium is constructed by the following method:
[0035] Step 1: Pick a single IMD4001 clone from the plate and inoculate it into 2 mL of seed culture medium A (2 g / L yeast extract, 2 g / L malt extract, 2 g / L glucose, 3% sea salt) and culture it at 30°C / 200 rpm overnight. Transfer the seed culture to 100 mL of culture medium B (50 g / L glucose, 10 g / L yeast extract, 6 g / L malt extract, 7% to 10% (w / v) sea salt) and the initial OD 600The value was 0.1, and the cells were cultured at 30℃ / 200rpm until the mid-logarithmic phase. The cells were collected by centrifugation and washed twice with sterile water. The cells were diluted to 10 7 ~10 8 CFU / mL, take 10μL of the suspension and drop it onto the ARTP mutagenic sterile iron sheet. After being treated by the ARTP mutation breeding system for 175 seconds, the cells were washed off the iron sheet using the seed culture medium and revived at 30℃ / 200rpm for 1 hour. The revived cells were transferred to culture medium B (containing 7% (w / v) sea salt) to enrich the salt-tolerant mutant strains in the ARTP mutagenic library.
[0036] Step 2: The MMC system further assists the evolution of Bacillus and improves salt tolerance. 5 mL of special oil was injected into three reagent bottles (No. 2, No. 4, and No. 6) of the MMC system, and then 10 mL of OD 600 The seed culture with a value of 0.1 was injected into bottle 2, 10 mL of medium B containing a% (w / v) sea salt was injected into bottle 4, and 10 mL of medium B containing b% (w / v) (b=a+1) sea salt was injected into bottle 6. The number of droplets formed was set to 50, and the automatic passage threshold was OD 600 =0.5, and the number of passages was set to 15 times.
[0037] Step 3: When the first round of MMC system acclimation experiment is over, select four droplets with good cell growth and culture them in the same fresh medium as bottle 6 until OD 600 The value reached about 1.0. The cells were collected and subjected to the next round of ARTP-MMC treatment, while the sea salt concentration in bottles 4 and 6 of the MMC system was increased by 1%.
[0038] Step 4: When the sea salt concentration in bottle 6 was increased to 10%, cell growth was severely inhibited, thus terminating the ARTP-MMC-assisted Bacillus evolution process. The droplet with the fastest cell growth was selected and cultured in medium B containing 10% sea salt until the OD 600 The value reached 1.0. The cell culture was appropriately diluted and coated on agar plates containing 10% sea salt in medium B. The culture was statically cultured at 30°C for 56 hours, and salt-tolerant domesticated strains with excellent performance were selected according to the colony size, and an excellent salt-tolerant strain numbered IMD4036 was obtained.
[0039] Through medium optimization, it was determined that the optimal fermentation medium for the original strain IMD4001 was medium C (50 g / L glucose, 10 g / L yeast extract, 6 g / L malt extract, 3% sea salt), and the optimal fermentation medium for the engineered strain IMD4036 was medium D (40 g / L glucose, 10 g / L yeast extract, 6 g / L malt extract). Under the respective optimal culture conditions, the macrolide and surfactant contents of the fermentation broths of IMD4001 and IMD4036 were detected by high performance liquid chromatography. The results are shown in Figure 1 As shown in the figure, under the optimal fermentation conditions, the titers of macrolide and fengycin in the fermentation broth of Bacillus engineered strain IMD4036 were 409.4±9.7μg / mL and 59.2±7.2μg / mL, and the yields were increased by 246.6% and -72.7% respectively compared with the control group IMD4001 ( Figure 1 According to the results of transcriptome research, the surfactant synthesis pathway of the strain was successfully activated by downregulating the transcription level of the Fengyuansu gene cluster, and the surfactant titer of IMD4036 fermentation broth was 252.4±57.5μg / mL ( Figure 1 Middle C).
[0040] Transcriptome sequencing technology was used to study the changes in the transcriptional levels of genes in the original strain IMD4001 and the engineered strain IMD4036. By enriching the metabolic pathways of the differentially expressed genes, it was found that the genes ppsA (-2.54), ppsB (-10.84) and ppsC (-1.61) of the fengyuan gene cluster were down-regulated. The surfactant synthesis gene cluster also had three genes srfAA (-2.98), srfAB (-2.46) and srfAD (-1.08) down-regulated. In the biosynthetic network of marine Bacillus, surfactants, macrolides and fengyuan compete with each other for precursor compounds, but fengyuan requires more energy and precursors. The synthesis of fengyuan is inhibited due to the down-regulation of the fengyuan synthesis pathway in IMD4036, which helps to improve / activate the surfactant synthesis of the strain, even if the expression level of the surfactant biosynthesis gene cluster is also reduced.
[0041] Example 2
[0042] The original strain IMD4001 and the Bacillus engineered strain IMD4036 were inoculated into medium A and cultured overnight at 30°C / 200rpm. 2mL of the culture was transferred to 100mL of medium A and cultured at 30°C / 200rpm to the middle of the logarithmic growth phase. The agricultural pathogenic strain was inoculated into medium E (10g / L tryptone, 5g / LNaCl, and 5g / L beef extract) and cultured at 30°C / 200rpm to the middle of the logarithmic phase. 50μL of the pathogenic bacteria culture was added to 50mL of liquid medium C / E (containing 2% agar powder), mixed evenly and the mixture was poured into a culture dish and solidified for 20min. 3μL of the original bacteria IMD4001 and the engineered strain IMD4036 logarithmic growth phase culture were added dropwise to the medium C plate and medium E plate containing agricultural pathogens, and cultured at 30°C for 40h. The inhibitory effects of IMD4001 and IMD4036 on various agricultural pathogens were judged based on the presence and size of inhibition zones.
[0043] Evaluation of the antibacterial activity of Bacillus engineered strain IMD4036 and original strain IMD4001 against agricultural pathogens. Fourteen different agricultural pathogens were used as research objects to evaluate the antibacterial activity of IMD4001 and IMD4036 against each pathogen (Table 1). IMD4001 showed antibacterial activity against four pathogens, including banana wilt, grape gray mold, sugarcane tip rot 2, and pitaya canker (Table 2, Figure 2 The Bacillus engineered strain IMD4036 showed inhibitory activity against banana wilt, grape gray mold 1, sugarcane tip rot 2 and pitaya canker, and also had inhibitory activity against another 4 pathogens including sugarcane tip rot 1, tomato bacterial wilt 1, monk fruit bacterial wilt and bitter melon bacterial wilt (Table 2, Figure 3 ).
[0044] Table 1 Study on the inhibition of original bacteria and engineered bacteria on different agricultural pathogens
[0045]
[0046] Note: “+” indicates inhibitory activity; “-” indicates no inhibitory activity
[0047] Table 2 Evaluation of the inhibitory activity of original bacteria and engineered bacteria on different agricultural pathogens
[0048]
[0049] Note: “-” indicates no inhibitory activity; Inhibition coefficient = transparent circle diameter / colony diameter
[0050] The above is only a preferred embodiment of the present invention. It should be pointed out that, for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A Bacillus engineered bacterium IMD4036, characterized in that: The Bacillus engineered bacteria IMD4036 is Bacillus velezensis, and the Bacillus engineered bacteria IMD4036 is deposited in the Guangdong Provincial Microbiological Culture Collection Management Center, with a deposit number of GDMCC No.64728 and a deposit date of June 7, 2024.
2. The Bacillus engineered bacteria IMD4036 according to claim 1, characterized in that The Bacillus engineering bacteria IMD4036 produces macrolide, surfactant and fengycin.
3. The Bacillus engineered bacteria IMD4036 according to claim 2, characterized in that: The titer of macrolide produced by the Bacillus engineered bacteria IMD4036 is not less than 350 μg / mL, the titer of surfactant produced by the Bacillus engineered bacteria IMD4036 is not less than 50 μg / mL, and the titer of fengycin produced by the Bacillus engineered bacteria IMD4036 is not less than 180 μg / mL.
4. The Bacillus engineered bacteria IMD4036 according to claim 1, characterized in that The engineered bacillus IMD4036 is obtained by iterative evolution of Bacillus IMD4001 assisted by ARTP mutagenesis and a microbial droplet culture system.
5. A method for constructing the Bacillus engineered bacterium IMD4036 according to any one of claims 1 to 4, characterized in that: The following steps are involved: Step 1: Pick a single clone of Bacillus IMD4001 and inoculate it into medium A for overnight culture to obtain a seed culture. Then transfer the seed culture to medium B. The initial OD 600 The value is 0.
1. After culturing to the mid-logarithmic phase, the cells are collected by centrifugation and washed with sterile water. The cells are diluted and the suspension is dropped onto the ARTP mutagenesis sterile iron sheet. After being treated by the ARTP mutation breeding system, the cells are washed off the iron sheet using the seed culture medium and revived. The revived cells are transferred to the culture medium B to enrich the salt-tolerant mutant strains in the ARTP mutagenesis library. Step 2, performing a first round of MMC system-assisted Bacillus evolution to improve the salt tolerance of the salt-tolerant mutant strain obtained in step 1; Step 3, when a second round of MMC system-assisted Bacillus evolution is performed, the salt tolerance of the salt-tolerant mutant strain is again improved until the salt concentration is too high to inhibit cell growth; Step 4: Select the droplet with the fastest cell growth in step 3 and culture it in medium B containing 10% sea salt until the OD 600 The value reached 1.0, and an excellent salt-tolerant strain numbered IMD4036 was obtained, which was the engineered Bacillus sp. IMD4036.
6. The construction method according to claim 5, characterized in that: The culture medium A includes 2 g / L yeast extract, 2 g / L malt extract, 2 g / L glucose and 3% (w / v) sea salt.
7. The construction method according to claim 5, characterized in that: The culture medium B includes 50 g / L glucose, 10 g / L yeast extract, 6 g / L malt extract and 7% to 10% (w / v) sea salt.
8. Use of the Bacillus engineered bacterium IMD4036 as claimed in any one of claims 1 to 4 as a bactericide.
9. A microbial agent, characterized in that: It comprises the Bacillus engineered bacteria IMD4036 as described in any one of claims 1 to 4.
10. Use of the microbial agent according to claim 9 in the prevention and treatment of sugarcane tip rot, banana wilt, grape gray mold, tomato bacterial wilt, monk fruit bacterial wilt, bitter melon bacterial wilt or pitaya canker.
Citation Information
Cited By
Genetically engineered bacterium for synergistically improving surfactin yield of bacillus by adopting key enzymes SrfAD and YbdT
CN116024147A
Genetic engineering bacteria using key enzymes SrfAD and YbdT to synergistically improve the high production of surfactin by Bacillus
CN116024147B
Bacillus velezensis engineering flora for preventing and controlling tomato bacterial wilt under salt stress and application of bacillus velezensis engineering flora
CN120192901A
